Literature DB >> 23670784

[Screening for depression by telephone using the German version of the Center for Epidemiological Studies Depression Scale (CES-D)].

Janine Stein1, Melanie Luppa1, Jette Mahnke1, Siegfried Weyerer2, Georg Schomerus3, Steffi G Riedel-Heller1.   

Abstract

OBJECTIVE: Analyses of the reliability and validity of the German version of the Center for Epidemiological Studies Depression Scale (CES-D) and the assessment of normative values.
METHOD: A representative sample of 868 people (German population, 18 to 94 years) was assessed via structured interviews in a telephone survey.
RESULTS: According to the cut-off score of 16 points, 8.5 % of the total sample (11.0 % women and 5.6 % men) showed relevant depressive symptoms. When using the cut-off score of 22 points, 3.5 % of the subjects of the total sample, 4.2 % of the women and 2.5% of the men, were classified as depressed. The analysis of the psychometric properties of the instrument such as internal consistency, test-retest reliability, construct validity and factor structure revealed moderate to good results. Percentile standard values were determined.
CONCLUSION: The German version of the CES-D can be described as a reliable and valid instrument for detecting depressive symptoms. The present study offers current normative data for the specific use in telephone surveys. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2013        PMID: 23670784     DOI: 10.1055/s-0033-1343176

Source DB:  PubMed          Journal:  Psychiatr Prax        ISSN: 0303-4259


  8 in total

1.  Psychiatric illness and length of stay in general hospitals: do case finding methods matter?

Authors:  Marion Freidl; Norbert Benda; Fabian Friedrich
Journal:  Neuropsychiatr       Date:  2015-04-28

2.  [Anchor-based ascertaining of meaningful changes in depressive symptoms using the example of the German short form of the CES-D].

Authors:  Ingo Haase; Markus Winkeler; Hartmut Imgart
Journal:  Neuropsychiatr       Date:  2016-06-14

3.  Symptoms and risk factors of depression during and after the football career of elite female players.

Authors:  Birgit Prinz; Jiří Dvořák; Astrid Junge
Journal:  BMJ Open Sport Exerc Med       Date:  2016-05-31

4.  Prevalence of depression and anxiety in top-level male and female football players.

Authors:  Astrid Junge; Nina Feddermann-Demont
Journal:  BMJ Open Sport Exerc Med       Date:  2016-01-19

5.  The effect of depressive symptomatology on the association of vitamin D and sleep.

Authors:  Roland Mergl; Ezgi Dogan-Sander; Anja Willenberg; Kerstin Wirkner; Jürgen Kratzsch; Steffi Riedel-Heller; Antje-Kathrin Allgaier; Ulrich Hegerl; Christian Sander
Journal:  BMC Psychiatry       Date:  2021-04-06       Impact factor: 3.630

6.  Fear of Infection and Depressive Symptoms among German University Students during the COVID-19 Pandemic: Results of COVID-19 International Student Well-Being Study.

Authors:  Franca Spatafora; Paula M Matos Fialho; Heide Busse; Stefanie M Helmer; Hajo Zeeb; Christiane Stock; Claus Wendt; Claudia R Pischke
Journal:  Int J Environ Res Public Health       Date:  2022-01-31       Impact factor: 3.390

7.  Serum anti-NMDA-receptor antibodies and cognitive function after ischemic stroke (PROSCIS-B).

Authors:  Thomas G Liman; Bob Siegerink; Pia S Sperber; Pimrapat Gebert; Leonie H A Broersen; Shufan Huo; Sophie K Piper; Bianca Teegen; Peter U Heuschmann; Harald Prüss; Matthias Endres
Journal:  J Neurol       Date:  2022-06-19       Impact factor: 6.682

8.  Eating Behaviour in the General Population: An Analysis of the Factor Structure of the German Version of the Three-Factor-Eating-Questionnaire (TFEQ) and Its Association with the Body Mass Index.

Authors:  Antje Löffler; Tobias Luck; Francisca S Then; Claudia Sikorski; Peter Kovacs; Yvonne Böttcher; Jana Breitfeld; Anke Tönjes; Annette Horstmann; Markus Löffler; Christoph Engel; Joachim Thiery; Arno Villringer; Michael Stumvoll; Steffi G Riedel-Heller
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.